Semaglutide · Published December 5, 2025 · Updated October 6, 2026 · 5 min read
Semaglutide Before and After: What the Evidence Shows
Before-and-after searches often lead to photos and monthly promises. This guide explains the measured trial result and the questions those claims leave unanswered.
Editorial disclosure: Written by Trimi Editorial Team. Trimi offers care that may include compounded medication. This is an explanation of published research and FDA guidance, not a patient testimonial or a report of Trimi outcomes. Sources were checked October 6, 2026. This update does not represent a new clinical review.
What do semaglutide before-and-after results actually show?
In STEP 1, adults without diabetes had a mean 14.9% reduction in body weight after 68 weeks of once-weekly semaglutide 2.4 mg plus lifestyle intervention, versus 2.4% with placebo plus lifestyle intervention. This study average is not a personal forecast or evidence of results with compounded semaglutide.
Read the original STEP 1 trial abstractWhat the STEP 1 trial measured
| Study detail | Published observation |
|---|---|
| Participants | 1,961 adults without diabetes; BMI at least 30, or at least 27 with a weight-related condition |
| Study design | Randomized, double-blind comparison of once-weekly subcutaneous semaglutide 2.4 mg and placebo |
| Other intervention | Lifestyle intervention in both groups |
| Measured endpoint | Mean change in body weight from baseline to week 68 |
| Reported result | 14.9% reduction with semaglutide; 2.4% reduction with placebo |
The 2021 STEP 1 publication reports an average across the study group. Novo Nordisk funded the trial. Its enrollment criteria describe the research population, not personal eligibility for a Trimi prescription.
The Wegovy prescribing information presents this trial as Study 2 of Wegovy injection. That identifies the branded-drug context of the evidence. The trial dose is a study detail, not an instruction to start or change a medication.
Why a study average is not a monthly forecast
You cannot divide an endpoint average into a reliable month-by-month prediction. Ask whether a claimed result comes from a measured time point in a named study, and whether its product and participants match the question being asked. A group average also does not say every participant reached that result.
For your own care, discuss response, tolerability and follow-up with your provider. Online timelines cannot determine when you should see a visible change or whether your treatment should change. Keep the study's observation separate from a prediction about your body.
What before-and-after photos cannot establish
A selected image or story leaves out the denominator: how many people started treatment and how many had a similar result. It also cannot establish which medication was used, the duration, concurrent care or relevant medical history. Even a documented individual experience would not establish what another person should expect.
This guide uses no patient transformations or composite stories. For an outcome claim, look for the original research, the measured endpoint and the product studied. If that information is missing, the claimed result remains unverified.
Branded-drug evidence and compounded semaglutide
A Wegovy study does not establish outcomes for compounded semaglutide. FDA's compounding questions and answers explain that compounded drugs are not FDA-approved and the agency does not verify their safety, effectiveness or quality before marketing. They are not FDA-approved generic drugs.
FDA says compounded drugs should be used only when a patient's medical needs cannot be met by an FDA-approved drug. Its GLP-1 guidancerecommends a prescription from a licensed clinician and dispensing through a state-licensed pharmacy. Discuss the specific product and why it is appropriate for you with your provider.
Questions to bring to your provider
- Which exact product are you proposing, and what evidence supports its use for my circumstances?
- What benefits, risks and uncertainties should I understand before deciding?
- How will we assess response and tolerability, and whom should I contact with questions?
- Which pharmacy will dispense it, and how can I verify its license and clarify the label?
For Trimi's published safety information, see Important Safety Information. A qualified healthcare provider determines whether a treatment is appropriate. This article provides general information and does not give personal dosing advice.
Frequently asked questions
How much weight did participants lose in STEP 1?
Mean body weight decreased 14.9% with semaglutide and 2.4% with placebo at week 68. Both groups received lifestyle intervention. These are group averages from a specific trial, not results every patient should expect.
Can I predict my semaglutide results at one, three or six months?
A 68-week average cannot establish your result at an earlier month. Your provider should assess your own treatment response and tolerability. A monthly forecast presented without a matching study population, product and measured time point is not reliable evidence for your outcome.
Do Wegovy trial results establish results for compounded semaglutide?
No. The branded-drug trial does not establish effectiveness or equivalence for a compounded preparation. Compounded drugs are not FDA-approved, and FDA does not verify their safety, effectiveness or quality before marketing.
Are before-and-after photos enough to judge expected results?
No. A selected photo cannot show how many people had a similar outcome, the exact product used, treatment duration or relevant health history. Use primary research and discuss its applicability with a licensed healthcare provider rather than treating a pictured result as a prediction.
What should I confirm before starting treatment?
Ask a licensed healthcare provider which specific product is appropriate, the benefits and risks for you, and how follow-up will work. Obtain a prescription and verify the dispensing pharmacy's state license. Ask the provider or pharmacist to clarify instructions instead of inferring a dose from an online result.
Primary sources and limits
Sources checked October 6, 2026. The trial figures above refer to STEP 1 and the studied branded-drug context. This guide does not measure Trimi patient outcomes, validate an individual before-and-after claim or establish effectiveness for a compounded preparation.